BioCryst Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

BioCryst Pharmaceuticals ( BCRX) is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. This stock closed up 3.4% to $7.24 in Thursday's trading session.

Thursday's Range: $6.96-$7.25
52-Week Range: $1.08-$7.41
Thursday's Volume: 1.39 million
Three-Month Average Volume: 2.51 million

>>5 Rocket Stocks to Buy for September Gains

From a technical perspective, BCRX jumped higher here with lighter-than-average volume. This stock has been trending sideways and consolidating for the last month and change, with shares moving between $6.07 on the downside and $7.41 on the upside. Shares of BCRX are now quickly moving within range of triggering a breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if BCRX manages to take out Thursday's high at $7.25 and its 52-week high at $7.41 with high volume.

Traders should now look for long-biased trades in BCRX as long as it's trending above some near-term support at $6.50 or at $6.07, and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.51 million shares. If that breakout hits soon, then BCRX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $9 to $10.

If you liked this article you might like

3 Biotech Stocks Under $10 to Watch

Biotech 2013 by the Numbers: A Blockbuster Year

Biotech Stock Mailbag: Idenix vs. Pharmasset?

Biotech Stock Mailbag: Idenix vs. Pharmasset?

Biotech Stock Mailbag: Generex

Biotech Stock Mailbag: Generex